NewsNation on MSN18h
AbbVie enters into almost $2B contract with Gubra for obsesity drugBloomberg reports the obesity drug market is expected to reach as much as $130 billion in annual sales by 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback